Cargando…
CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor
KRAS-driven non-small cell lung cancer (NSCLC) patients have no effective targeted treatment. In this study, we aimed to investigate targeting epidermal growth factor receptor (EGFR) as a therapeutic approach in KRAS-driven lung cancer cells. We show that ablation of EGFR significantly suppressed tu...
Autores principales: | Liu, Bin, Song, Shanshan, Setroikromo, Rita, Chen, Siwei, Hu, Wenteng, Chen, Deng, van der Wekken, Anthonie J., Melgert, Barbro N., Timens, Wim, van den Berg, Anke, Saber, Ali, Haisma, Hidde J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520904/ https://www.ncbi.nlm.nih.gov/pubmed/30935067 http://dx.doi.org/10.3390/cancers11040455 |
Ejemplares similares
-
D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling
por: Song, Shanshan, et al.
Publicado: (2021) -
Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer
por: Saber, Ali, et al.
Publicado: (2016) -
CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD
por: Falk, Mads Krüger, et al.
Publicado: (2014) -
Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
por: Lu, Minmin, et al.
Publicado: (2022) -
Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation
por: Rowinska, Zuzanna, et al.
Publicado: (2017)